ロード中...
In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition
BACKGROUND: Despite great development in genome and proteome high-throughput methods, treatment failure is a critical point in the management of most solid cancers, including breast cancer (BC). Multiple alternative mechanisms upon drug treatment are involved to offset therapeutic effects, eventuall...
保存先:
| 出版年: | J Transl Med |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989433/ https://ncbi.nlm.nih.gov/pubmed/29871693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1535-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|